CHB
Global X China Biotech Innovatio
CHB
6,64
0,00 Bil. AUM
0,6% Expense Ratio
6,72 NAV
Global X China Biotech Innovatio Profile
About Global X China Biotech Innovatio
The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China’s biotechnology industry. It is non-diversified.
- Company
- Global X
- Holdings
- 2
- CUSIP
- 37954Y251
Global X China Biotech Innovatio Sectors
| Industry | Percentage |
|---|---|
| Healthcare | 99,16% |
| Basic Materials | 0,84% |
| Technology | 0,00% |
| Real Estate | 0,00% |
| Industrials | 0,00% |
| Financial Servic | 0,00% |
| Energy | 0,00% |
| Consumer Defensi | 0,00% |
| Consumer Cyclica | 0,00% |
| Communication Se | 0,00% |
| Utilities | 0,00% |